December 1, 2020
Could regenerative medicine provide a new approach to diabetes care?
November is National Diabetes Month, a time to reflect on new ways to manage a chronic condition that affects young and old. Mayo Clinic is applying a regenerative lens to advancing diabetes care beyond routine blood checks and standard insulin therapy. Quinn Peterson, Ph.D.; Aleksey Matveyenko, Ph.D.; and Alexander Revzin, Ph.D., are collaborating on a […]
Tags: Aleksey Matveyenko, Alexander Revzin, animal model, cell replacement therapy, Center for Regenerative Medicine, Centers for Disease Control and Prevention, diabetes, Quinn Peterson, stem cells
May 21, 2020
A discovery step toward cell replacement therapy for diabetes
In what could be a step toward cell replacement therapy for diabetes, Mayo Clinic researchers have discovered how to manufacture cells capable of generating a hormone that regulates low blood sugar. Quinn Peterson, Ph.D. and his team have developed a new method of mass producing a cell product containing the hormone glucagon that is capable […]
Tags: Center for Regenerative Medicine, diabetes, hypoglycemia, Quinn Peterson, stem cells